Clinical Trial of the Effects of DHA in the Treatment of Seizure Disorders

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Epilepsy (Treatment Refractory)
Interventions
DIETARY_SUPPLEMENT

Fish Oil

The daily dose is divided; capsules are taken with meals for a period of 6 months.

OTHER

Safflower Oil

Daily dose of safflower oil taken in divided doses as capsules and consumed with meals.

Trial Locations (2)

M2K 1E1

North York General Hospital, Toronto

Unknown

Toronto Western Hospital, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

North York General Hospital

OTHER

collaborator

Ontario Brain Institute

OTHER

collaborator

University Health Network, Toronto

OTHER

lead

The Canadian College of Naturopathic Medicine

OTHER